Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43399 | 31834843 | J Med Food | Natural Products: New Hope for Nonalcoholic Steatohepatitis? | 2019 | Details |
| A43400 | 31823402 | J Food Biochem | Comparative effects of nanoemulsions loaded with duck oil and lard oil on palmitate-induced lipotoxicity. | 2019 | Details |
| A43401 | 31823334 | Probiotics Antimicrob Proteins | Therapeutic and Nutritional Effects of Synbiotic Yogurts in Children and Adults: a Clinical Review. | 2020 | Details |
| A43402 | 31822338 | Presse Med | [Editorial]. | 2019 | Details |
| A43403 | 31820180 | Dig Dis Sci | Cardiovascular Risk in NAFLD: An Intimate Relationship? | 2020 | Details |
| A43404 | 31813639 | Lancet | Obeticholic acid: towards first approval for NASH. | 2019 | Details |
| A43405 | 31813574 | J Hepatol | Predicting NASH response with liver fat: Are we back to square one? | 2019 | Details |
| A43406 | 31812989 | Alcohol Alcohol | Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study. | 2020 | Details |
| A43407 | 31812470 | Clin Nutr | Reply-Letter to the Editor: Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease. | 2019 | Details |
| A43408 | 31809300 | Am J Gastroenterol | Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease? | 2020 | Details |
| A43409 | 31804018 | Obesity (Silver Spring) | Obesity Predicts Liver Function Testing and Abnormal Liver Results. | 2019 | Details |
| A43410 | 31801050 | Eur J Prev Cardiol | Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease. | 2019 | Details |
| A43411 | 31800715 | Arq Bras Cardiol | A New Rodent Model of Non-Alcoholic Steatohepatitis and Metabolic Syndrome. | 2019 | Details |
| A43412 | 31791671 | Clin Nutr | Low-carbohydrate diets and intrahepatic lipid content in individuals with non-alcoholic fatty liver disease: Evidence from a meta-analysis of randomized trials. | 2019 | Details |
| A43413 | 31791052 | Ann Intern Med | How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease? | 2019 | Details |
| A43414 | 31791051 | Ann Intern Med | How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease? | 2019 | Details |
| A43415 | 31787171 | Presse Med | [Nutritional steatosis a drug target, or more especially anchor point for a holistic approach?] | 2019 | Details |
| A43416 | 31785257 | Metabolism | Adiponectin and leptin in the diagnosis and therapy of NAFLD. | 2019 | Details |
| A43417 | 31781941 | J Gastroenterol | Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients? | 2019 | Details |
| A43418 | 31765518 | J Diabetes Investig | Are the polyol pathway and hyperuricemia partners in the development of non-alcoholic fatty liver disease in diabetes? | 2020 | Details |
| A43419 | 31764586 | J Hypertens | Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient. | 2020 | Details |
| A43420 | 31758706 | Hepatology | REPLY. | 2020 | Details |
| A43421 | 31757812 | BMJ | Studies on non-alcoholic fatty liver disease should stratify by disease severity. | 2019 | Details |
| A43422 | 31757800 | BMJ | Authors' reply to McKenna-Barry and Ryan. | 2019 | Details |
| A43423 | 31755564 | Hepatology | Letter to the Editor: Does the HSD17B13 rs72613567 Splice Variant Actually Yield a New Type of Alternative Splicing? | 2020 | Details |
| A43424 | 31754957 | Hepatol Int | Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease. | 2019 | Details |
| A43425 | 31754898 | Curr Diab Rep | Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes. | 2019 | Details |
| A43426 | 31752528 | Exp Biol Med (Maywood) | Mixture of blackberry leaf and fruit extracts alleviates non-alcoholic steatosis, enhances intestinal integrity, and increases Lactobacillus and Akkermansia in rats. | 2019 | Details |
| A43427 | 31740806 | Nat Rev Gastroenterol Hepatol | What's new in NAFLD pathogenesis, biomarkers and treatment? | 2020 | Details |
| A43428 | 31740030 | Lancet | Improving NASH with a little help from thyromimetics. | 2019 | Details |
| A43429 | 31737665 | Biomed Res Int | Lipid Metabolism Alterations in a Rat Model of Chronic and Intergenerational Exposure to Arsenic. | 2019 | Details |
| A43430 | 31737070 | Int J Endocrinol | Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications. | 2019 | Details |
| A43431 | 31732172 | J Neurol Sci | Response to letter to the editor by Kawada on "Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke". | 2019 | Details |
| A43432 | 31728756 | Endocrine | Liver-derived FGF21 is essential for full adaptation to ketogenic diet but does not regulate glucose homeostasis. | 2019 | Details |
| A43433 | 31727327 | J Neurol Sci | Nonalcoholic fatty liver disease with advanced fibrosis, stroke and cardiovascular disease. | 2019 | Details |
| A43434 | 31722058 | Dig Dis Sci | Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C. | 2019 | Details |
| A43435 | 31718777 | Aten Primaria | [The fatty liver epidemic: An analysis from the primary care]. | 2019 | Details |
| A43436 | 31715175 | Metabolism | Metabolism updates: new directions, techniques, and exciting research that is broadening the horizons. | 2019 | Details |
| A43437 | 31714988 | JAMA | Testing for Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43438 | 31711877 | Metabolism | Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A "non-invasive alternative" to liver biopsy? | 2019 | Details |
| A43439 | 31709613 | Aliment Pharmacol Ther | Editorial: evolving histological assessment of NASH. Authors' reply. | 2019 | Details |
| A43440 | 31709610 | Aliment Pharmacol Ther | Editorial: evolving histological assessment of NASH. | 2019 | Details |
| A43441 | 31709046 | Clin Liver Dis (Hoboken) | Relationship of Physician Counseling to Weight Loss Among Patients With Nonalcoholic Fatty Liver Disease: An Observational Cohort Study Using National Health and Education Survey Data. | 2019 | Details |
| A43442 | 31701542 | Hepatology | Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases. | 2019 | Details |
| A43443 | 31701074 | Hepatol Commun | Incidence of and Risk Factors for Hepatic Encephalopathy in a Population-Based Cohort of Americans With Cirrhosis. | 2019 | Details |
| A43444 | 31698503 | Hepatology | γδT Cells and CD1d, Novel Immune Players in Alcoholic and Nonalcoholic Steatohepatitis? | 2019 | Details |
| A43445 | 31694274 | Cancers (Basel) | Carcinogenesis and Metastasis in Liver: Cell Physiological Basis. | 2019 | Details |
| A43446 | 31694146 | Nutrients | Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk. | 2019 | Details |
| A43447 | 31694085 | Diabetes Metab J | Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis. | 2019 | Details |
| A43448 | 31693811 | N Engl J Med | Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides. | 2019 | Details |
| A43449 | 31680302 | Hepatology | Reply. | 2020 | Details |
| A43450 | 31680281 | Hepatology | Liver Fat and Cardiometabolic Risk Factors Among School-Age Children. | 2020 | Details |
| A43451 | 31680275 | Hepatology | Letter to the Editor: Modest Alcohol Consumption and Nonalcoholic Fatty Liver Disease: An Oxymoron? | 2020 | Details |
| A43452 | 31677326 | Liver Int | Reply to: Influence of Helicobacter pylori-connected metabolic syndrome on nonalcoholic fatty liver disease and its related colorectal neoplasm high risk. | 2019 | Details |
| A43453 | 31677320 | Liver Int | Cognitive impairment in patients with nonalcoholic fatty liver disease with liver fibrosis. | 2019 | Details |
| A43454 | 31673545 | Hepatobiliary Surg Nutr | Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed? | 2019 | Details |
| A43455 | 31673541 | Hepatobiliary Surg Nutr | Relative skeletal muscle mass and non-alcoholic fatty liver disease: from association to causation. | 2019 | Details |
| A43456 | 31673540 | Hepatobiliary Surg Nutr | Increasing contribution of non-alcoholic fatty liver disease to hepatocellular carcinoma incidence and mortality in U.S. Medicare. | 2019 | Details |
| A43459 | 31665185 | PLoS One | Correction: Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight. | 2019 | Details |
| A43460 | 31663469 | Curr Med Chem | Effects of Pterostilbene on Diabetes, Liver Steatosis and Serum Lipids. | 2021 | Details |
| A43461 | 31657474 | Aliment Pharmacol Ther | Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply. | 2019 | Details |
| A43462 | 31657472 | Aliment Pharmacol Ther | Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A43463 | 31657225 | Am J Physiol Gastrointest Liver Physiol | Role of gut microbiota in liver disease. | 2019 | Details |
| A43464 | 31653320 | Clin Gastroenterol Hepatol | Reply. | 2019 | Details |
| A43465 | 31653319 | Clin Gastroenterol Hepatol | The Importance of Amerindian Ancestry on Nonalcoholic Fatty Liver Disease in the Hispanic/Latino American Population. | 2019 | Details |
| A43466 | 31650253 | Acta Diabetol | Reply to Letter to the editor regarding "The ZJU index is a powerful index for identifying NAFLD in the general Chinese population". | 2019 | Details |
| A43467 | 31649796 | Prz Gastroenterol | Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived? | 2019 | Details |
| A43468 | 31649547 | Front Pharmacol | Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns. | 2019 | Details |
| A43469 | 31648031 | Clin Gastroenterol Hepatol | Poor Concordance Between Liver Stiffness and Noninvasive Fibrosis Scores in HIV Infection Without Viral Hepatitis. | 2019 | Details |
| A43470 | 31633718 | Arq Gastroenterol | NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), MORE THAN A LIVER DISEASE. | 2019 | Details |
| A43471 | 31628635 | Hormones (Athens) | Asporin levels are low in patients with nonalcoholic fatty liver disease and increase after vitamin E treatment. | 2019 | Details |
| A43472 | 31625368 | Clin Lab | Is Urinary Transferrin an Independent Risk Factor for Nonalcoholic Fatty Liver Disease? | 2019 | Details |
| A43473 | 31617122 | Ann Surg Oncol | Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases. | 2019 | Details |
| A43474 | 31615278 | Expert Opin Investig Drugs | A role for IL-1 inhibitors in the treatment of non-alcoholic fatty liver disease (NAFLD)? | 2019 | Details |
| A43475 | 31613385 | Hepatology | Reply. | 2020 | Details |
| A43476 | 31611648 | Nat Rev Endocrinol | The clinical potential of circulating microRNAs in obesity. | 2019 | Details |
| A43477 | 31611037 | Lancet HIV | Tesamorelin, liver fat, and NAFLD in the setting of HIV. | 2019 | Details |
| A43478 | 31610029 | Hepatology | Letter to the Editor: Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43479 | 31609939 | Pancreas | Factors Affecting Nonalcoholic Fatty Liver Disease After Pancreatic Head Resection. | 2019 | Details |
| A43480 | 31606781 | Acta Diabetol | Letter to the editor regarding "The ZJU index is a powerful index for identifying NAFLD in the general Chinese population". | 2019 | Details |
| A43481 | 31603713 | Arch Pathol Lab Med | Fatty Liver Disease: A Practical Approach. | 2019 | Details |
| A43482 | 31603197 | J Nutr | Expand SNAP to Reduce Nonalcoholic Fatty Liver Disease in the United States. | 2020 | Details |
| A43483 | 31597437 | Angiology | Reply to the Letter to the Editor Entitled: "The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases". | 2019 | Details |
| A43484 | 31595532 | Hepatology | Letter to the Editor: Chronic Hepatitis B and Nonalcoholic Steatohepatitis: Is "Fat" All Bad? | 2020 | Details |
| A43485 | 31593309 | Hepatology | Reply. | 2020 | Details |
| A43486 | 31592705 | Metab Syndr Relat Disord | Triglycerides as a Metabolic Target in Afrocaribbean Infertile Women with Polycystic Ovary Syndrome. | 2019 | Details |
| A43487 | 31592491 | Hepatol Commun | Cost Saving or Cost Effective? Unanswered Questions in the Screening of Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43488 | 31591781 | Aliment Pharmacol Ther | Letter: probiotics? Yes, but which ones? Authors' reply. | 2019 | Details |
| A43489 | 31591768 | Aliment Pharmacol Ther | Letter: probiotics? Yes, but which ones? | 2019 | Details |
| A43490 | 31590050 | Colloids Surf B Biointerfaces | Fe3O4@OA@Poloxamer nanoparticles lower triglyceride in hepatocytes through liposuction effect and nano-enzyme effect. | 2019 | Details |
| A43491 | 31587862 | J Pediatr | Impact of Bariatric Surgery on Adipose Tissue and Liver Inflammation in Adolescents with Nonalcoholic Steatohepatitis. | 2019 | Details |
| A43492 | 31587376 | Biofactors | Discovery of a role of the novel hepatokine, hepassocin, in obesity. | 2019 | Details |
| A43493 | 31587343 | Hepatology | Letter to the Editor: Impact of Nonalcoholic Steatohepatitis on Liver-Related Outcomes in Chronic Hepatitis B. | 2020 | Details |
| A43494 | 31586595 | J Hepatol | Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver? | 2019 | Details |
| A43495 | 31586267 | Hepatol Int | Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease. | 2019 | Details |
| A43496 | 31584530 | J Cardiovasc Pharmacol | NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium. | 2019 | Details |
| A43497 | 31582899 | Mediators Inflamm | Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases. | 2019 | Details |
| A43498 | 31580238 | Exp Clin Transplant | Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Iranian Patients. | 2019 | Details |
| A43499 | 31580165 | Biomark Med | Variations in laboratory parameters in prechronic disease to determine disease occurrence at the molecular level. | 2019 | Details |
| A43500 | 31576746 | Chem Res Toxicol | Dose-Dependent Effects of Triclocarban Exposure on Lipid Homeostasis in Rats. | 2019 | Details |